US 8877759
Aminopyrazines as ATR kinase inhibitors
granted A61KA61K31/497A61K31/501
Quick answer
US patent 8877759 (Aminopyrazines as ATR kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/497, A61K31/501, A61K31/5377, A61K31/55